QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SI

QT70Shoulder Innovations, Inc.
NYSE·Healthcare·Medical - Specialties·USA
Latest market price
18.55
+0.58+3.23%
OverviewShort InterestFilings
SIQT70Shoulder Innovations, Inc.·NYSE
OverviewShort InterestFilings
18.55+3.23%
TA
Loading chart...
Screen all →
MOBI-1.93%$14.25LLY-1.21%$1098.57JNJ-2.48%$228.39ABBV-2.08%$216.63UNH+0.36%$400.96NVS-2.52%$147.08MRK-1.36%$113.87AZN-1.66%$174.93
Snapshot
Index-P/E-EPS (ttm)-2.17
Insider Own13.27%
Shs Outstand20.74M
Perf Week-1.12%
Market Cap372.67MForward P/E-EPS next Y-1.37Insider Trans0.92%Shs Float-Perf Month24.25%
Enterprise Value376.18MPEG0.09EPS next Q-0.46Inst Own-Short Float-Perf Quarter23.26%
Income-44272711.00P/S6.91EPS this Y21.63%Inst Trans-Short Ratio-Perf Half Y13.11%
Sales53.89MP/B2.79EPS next Y19.24%ROA-27.49%Short Interest-Perf YTD29.72%
Book/sh6.41P/C-EPS next 5Y-ROE-35.31%52W High-Perf Year-
Cash/sh5.26P/FCF-EPS past 3/5Y-ROIC-20.92%52W Low-Perf 3Y-
Dividend Est.-EV/EBITDA-8.70Sales past 3/5Y-Gross Margin75.48%Volatility5.40% 3.96%Perf 5Y-
Dividend TTM-EV/Sales6.98EPS Y/Y TTM-8437.66%Oper. Margin-57.48%ATR (14)1.09Perf 10Y-
Dividend Ex-Date-Quick Ratio10.04Sales Y/Y TTM68.75%Profit Margin-81.78%RSI (14)67.71Recom2.00
Dividend Gr. 3/5Y-Current Ratio11.81EPS Q/Q-77.90%SMA2016.50%Beta0.66Target Price19.00
Payout0.00%Debt/Eq0.11Sales Q/Q70.00%SMA5025.93%Rel Volume1.07Prev Close17.97
Employees300LT Debt/Eq0.10EarningsSep 08SMA20031.83%Avg Volume84.10KPrice18.55
IPO DateJul 31, 2025Option/ShortYes / YesEPS/Sales Surpr.6.82% 13.33%Net Debt/EBITDA-0.08Volume90,244Change3.23%
Analyst Ratings
DateActionAnalystRatingTarget
May-08-26ReiteratedPiper SandlerOverweight$18 → $19
Dec-02-25ReiteratedMorgan StanleyOverweight$18 → $23
Aug-25-25InitiatedMorgan StanleyOverweight$13 → $18
Aug-25-25InitiatedJefferiesBuy$19
Aug-25-25InitiatedPiper SandlerOverweight$18
Aug-25-25InitiatedGoldman SachsBuy$10 → $20
Jan-09-23ReiteratedMorgan Stanley$24 → $13
Jan-09-23ReiteratedWedbush$45 → $9.00
Jan-09-23ReiteratedGoldman Sachs$35 → $10
Jan-06-23ReiteratedWells Fargo$16 → $8.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue544732
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A13117
Gross Profit413624
Selling, General and Administrative Excl. Other615535
Research and Development1084
Other Operating Expense2-10
Operating Income-31-26-15
Interest Expense-101
Unusual Expense
———
Non-Operating Income (Expense)14140
Net Income Before Taxes-44-40-16
Income Taxes
000
Consolidated Net Income-44-40-16
Net Income From Continuing Operations-44-40-16
Net Income-44-40-16
EPS (Recurring)-2.17-1.96-0.77
EPS (Basic, Before Extraordinaries)-2.17-1.96-0.77
EPS (Diluted)-2.17-1.96-0.77
EBITDA-41-37-12
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio7.216.39—
Gross Margin75.9376.6075.00
Operating Margin-57.41-55.32-46.88
Net Margin-81.48-85.11-50.00
Shares Outstanding212120
Market Capitalization390300—
Operating Lease Expense
———
Insider Trading Volume
$20.11$18.12$16.13$14.15$12.16● Close Price0.00K93.56K187.13K280.69K374.25KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Ahearn Matthew FraserChief Operating OfficerJun 15 '26Sale18.844,14478,070269,176Jun 16 12:00 AM
Ahearn Matthew FraserChief Operating OfficerJun 12 '26Sale18.6815,856296,185273,320Jun 16 12:00 AM
Ball Robert JosephCEO & Executive ChairmanApr 30 '26Option Exercise2.4820,00049,608309,756Apr 30 12:00 AM
Ahearn Matthew FraserChief Operating OfficerApr 20 '26Option Exercise2.7343,328118,340286,765Apr 21 12:00 AM
Buchholz RichardDirectorMar 13 '26Buy14.841,00014,84013,666Mar 17 12:00 AM
Ball Robert JosephCEO & Executive ChairmanMar 13 '26Buy15.182,20033,392278,866Mar 17 12:00 AM
BUCKMAN PAULDirectorMar 13 '26Option Exercise2.2691,212206,24265,710Mar 17 12:00 AM
Points Jeffrey S.Chief Financial OfficerMar 13 '26Buy15.002,00030,00070,785Mar 17 12:00 AM
Points Jeffrey S.Chief Financial OfficerMar 13 '26Option Exercise2.4826,52865,80068,785Mar 17 12:00 AM
Ball Robert JosephCEO & Executive ChairmanFeb 06 '26Option Exercise2.4224,12458,264319,756Feb 10 12:00 AM
Ball Robert JosephCEO & Executive ChairmanDec 12 '25Buy14.893,90058,075118,457Dec 15 12:00 AM
Points Jeffrey S.Chief Financial OfficerDec 12 '25Buy14.981,00515,05554,445Dec 15 12:00 AM
Ball Robert JosephCEO & Executive ChairmanDec 11 '25Buy14.833,30048,934114,557Dec 15 12:00 AM
Points Jeffrey S.Chief Financial OfficerDec 11 '25Buy14.6599514,57753,440Dec 15 12:00 AM
Fraher KathleenChief Transition OfficerNov 19 '23Option Exercise0.002,406012,571Nov 21 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR